| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 13, 2021 | Moleculin Receives Approval to Extend Dose Escalation in Phase 1/2 European Clinical Trial Evaluating Annamycin for the Treatment of Acute Myeloid Leukemia | |
| Jun 21, 2021 | Moleculin Announces First Subject Enrolled and Dosed in Phase 1b/2 Clinical Trial of Annamycin for the Treatment of Sarcoma Lung Metastases | |
| Jun 15, 2021 | Moleculin Announces Inclusion in the Russell 2000® Index | |
| May 14, 2021 | MOLECULIN BIOTECH, INC.
Moleculin Biotech : Reports First Quarter 2021 Financial Results and Provides Programs Update (Form 8-K) | Moleculin Reports First Quarter 2021 Financial Results and Provides Programs Update
- Multiple ongoing clinical studies expected to drive key clinical and regulatory milestones throughout next 18 months -
- Significantly strengthened financ... |
| May 12, 2021 | Moleculin Reports First Quarter 2021 Financial Results and Provides Programs Update | |
| May 11, 2021 | MOLECULIN BIOTECH, INC.
Moleculin Biotech : WPD Pharmaceuticals to Receive $6.7 Million Grant for Development of Annamycin Drug Candidate | VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical-stage pharmaceutical company, is pleased to announce that it has been conditionally awarded a ... |
| Apr 14, 2021 | Moleculin Awarded New Rare Pediatric Disease Designation from U.S. FDA for WP1066 for the Treatment of Ependymoma | |
| Mar 30, 2021 | Moleculin Receives FDA Approval of Fast Track Designation for Annamycin in the Treatment of Sarcoma Lung Metastases | |
| Mar 24, 2021 | Moleculin Biotech, Inc. Reports Financial Results for the Year Ended December 31, 2020 | |
| Mar 19, 2021 | Houston energy startup acquired by growing tech company | February's massive winter weather disaster underscored the fragile availability and volatile cost of electricity in the Houston area and throughout Texas. Just a month after the calamity, a Washington, D.C.-based company has scooped up Hous... |
| Mar 17, 2021 | Tech exec shares how she's excited to 'make a splash' in Houston with recent expansion | When Rachel Moncton decided she wanted to move back to the United States after years of growing consumer tech company ClassPass internationally, she had no clue where she was going to end up.
The current vice president of marketing had serv... |
| Mar 16, 2021 | How Houston small businesses can stand out when competing for in-demand talent | As the economic recovery gears up, small business owners increasingly need to hire and retain the best talent available in their industry. The challenge for small- and medium-sized business owners is how to compete with large corporations t... |
| Mar 16, 2021 | Panel: How ESG is affecting the energy transition | Editor's note: For SXSW 2021, the Greater Houston Partnership produced two days of interviews and panels hosted by me — Natalie Harms, editor of InnovationMap — and focused on Houston innovation. One focused on how Houston is leading the en... |
| Mar 15, 2021 | New report shows what industries in Houston are attracting the most venture capital investment | According to a recently released report, a few key industries in Houston have attracted the bulk of the city's venture capital investment dollars.
The Houston Tech Report by the Greater Houston Partnership and Houston Exponential has reveal... |
| Mar 12, 2021 | 5 most popular innovation stories in Houston this week | Editor's note: Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup news on InnovationMap included innovators to know, a guest column about addressing the digi... |
| Mar 12, 2021 | 7 can't-miss events at virtual SXSW featuring Houston speakers | Many Houstonians were hoping to be able head out to Austin next week for SXSW 2021, but now they don't have to venture out from behind their computer screens.
SXSW has pivoted to virtual this year, but the online schedule still features all... |
| Mar 11, 2021 | How technology helped Houston fight against the pandemic | The entire world came to a standstill when the COVID-19 pandemic came knocking at the door, and Houston was no different than the rest. Businesses got shut down, people were losing jobs left and right, the medical infrastructure was wheezin... |
| Mar 11, 2021 | Houston experts: Diversity is key to venture capital success | Venture capital firms across the board have a goal of driving a return on their investments, but getting a good ROI and factoring in diversity and inclusion into the equation are not mutually exclusive.
In fact, on a panel at the HX Venture... |
| Mar 11, 2021 | The future of Houston's economy shines bright, according to new report | The Houston metro area shed 141,300 jobs last year — the worst one-year job loss ever recorded in the region — and the area's unemployment rate peaked at 14.3 percent last April. But, according to a new ranking, there's at least one bright ... |
| Mar 10, 2021 | Houston startup plans to expand to revolutionize tech-enabled small business support | Hiring and recruiting has been a challenging and inefficient process for small businesses — yet it could not be more important as a company with a small, growing team.
"Today, whether you're running a startup for the first or second ti... |
| Mar 10, 2021 | Rice University's Shell-backed hub announces latest research grants | Several clean energy research teams have been awarded grants from a Rice University hub that focuses on innovating zero-emissions technology.
The Carbon Hub has awarded seven seed grants to research teams working on solutions for clean ener... |
| Mar 9, 2021 | Houston expert: Three steps community organizations can take to close the digital divide | The pandemic has had a devastating impact on low-income communities. On top of job losses and a greater risk of exposure to COVID-19, people in disadvantaged neighborhoods face another significant hurdle: access to technology.
In communitie... |
| Feb 25, 2021 | Chevron's Houston-based venture arm launches $300M fund focusing on low-carbon tech | Chevron Corp.'s investment arm has launched a $300 million fund that will focus on low-carbon technology.
Chevron Technology Ventures LLC's Future Energy Fund II builds on the success of the first Future Energy Fund, which kicked off in 201... |
| Feb 23, 2021 | This Texas company is on a mission to the moon with $93 million NASA contract | A local aerospace company is over the moon about its latest endeavor: a NASA-funded project to deliver scientific payloads to the lunar surface.
NASA recently awarded rocket-maker Firefly Aerospace $93.3 million to deliver a suite of scienc... |
| Feb 22, 2021 | Two female founders create a PR solution for startups and small businesses in Houston and beyond | Public relations can feel elusive and overwhelming to small business owners. Carla Nikitaidis and Kathryn Worsham Humphries, two seasoned communications consultants, are used to hearing clients ask if they need PR — and more often than not,... |
| Feb 22, 2021 | SBA launches Virtual Business Recovery Center to assist Texas loan applicants after winter storm | Texas small businesses impacted by Winter Storm Uri are now eligible for up to $2 million in low-interest loans from the U.S. Small Business Administration as a result of President Joe Biden's major disaster declaration last week.
"Get... |
| Feb 10, 2021 | Moleculin Announces Full Exercise of Over-Allotment Option | |
| Feb 8, 2021 | Moleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung Metastases | |
| Feb 3, 2021 | Moleculin Announces Pricing Of $67.8 Million Underwritten Public Offering | |
| Feb 3, 2021 | Houston biotech startup announces merger and $10M series A | A Houston company has emerged from stealth mode to announce a merger and a round of financing.
Coya Therapeutics, a clinical-stage biotech startup that focuses on creating therapeutics for neurodegenerative and autoimmune diseases, announce... |
| Feb 2, 2021 | Moleculin Announces Proposed Underwritten Public Offering | |
| Feb 2, 2021 | Moleculin Announces 100% Survival Achieved in Osteosarcoma Lung Metastases Animal Model | |
| Jan 29, 2021 | Moleculin Announces Reverse Stock Split | |
| Jan 15, 2021 | 5 most popular innovation stories in Houston this week | Editor's note: Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup news on InnovationMap included top a female-founded startup that helps busy families manage... |
| Jan 13, 2021 | Local fund of funds to put a national spotlight on venture capital in Houston | The role of the HX Venture Fund is to pull out-of-Houston venture capital funds into the Houston innovation ecosystem — and the fund of funds is hoping to exactly that with an inaugural event next month.
Venture Houston, which is taking pla... |
| Jan 5, 2021 | 8+ can't-miss Houston business and innovation events online in January | It's a whole new year, but Houston is cranking out the same great business and innovation-focused events.
Here's a roundup of virtual events not to miss this month — from workshops and webinars to summits and pitch parties. Note: This post ... |
| Dec 29, 2020 | Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas | |
| Dec 24, 2020 | 5 most popular innovation stories in Houston this week | Editor's note: Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup news on InnovationMap included 2020 in review roundups, Microsoft signing a lease in The Io... |
| Dec 21, 2020 | Houston blockchain startup closes $3 million seed led by local VC | A Houston-based blockchain company that focuses on providing companies with ethical and sustainable practices within the supply chain has closed a $3 million round with support from investors both locally and across the country.
Today, Topl... |
| Dec 17, 2020 | Moleculin Announces FDA Permission to Begin Clinical Study of Annamycin for Sarcoma Lung Metastases | |
| Dec 1, 2020 | Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066 | |
| Nov 19, 2020 | Moleculin Announces New Data Demonstrating Synergistic Antitumor Activity of Annamycin Combination with Ara-C in AML | |
| Nov 17, 2020 | Houston investment platform acquired, new partnership grows investor access | A growing New York-based private investment platform has acquired Houston-based NextSeed, according to announcements from both companies.
Republic announced the acquisition Monday, November 16, and appointed Youngro Lee, co-founder and CEO ... |
| Nov 13, 2020 | Moleculin Biotech, Inc. Reports Financial Results for the Quarter Ended September 30, 2020 | |
| Nov 4, 2020 | Houston-founded venture capital firm heads into second fund focused on social impact | When it comes to business, creating a social impact and a profitable business strategy aren't mutually exclusive — especially nowadays — and a Houston-founded venture capital firm is striving to invest in seed-stage tech companies that chec... |
| Sep 24, 2020 | Houston biotech company launches animal testing on a drug that could treat COVID-19 | A clinical stage pharmaceutical company based in Houston has entered into the next phase of testing out a drug that could be used to treat COVID-19.
Moleculin Biotech Inc. has tapped an independent lab to examine the antiviral activity of i... |
| Jun 25, 2020 | Startup closes series A, Houston hospital taps into new tech, and more local innovation news | Houston's innovation ecosystem has been booming with news, and it's likely some might have fallen through the cracks.
For this roundup of short stories within Houston innovation, Deloitte is looking for tech companies to honor, a few Housto... |
| May 29, 2020 | 5 most popular innovation stories in Houston this week | Editor's note: Houston innovation news has geared up with headlines of major personnel changes, research projects — COVID-19 and otherwise, and more. See below for this week's top five stories of innovation news in Houston.
3 Houston innova... |
| Apr 15, 2020 | These 7 Houston health tech companies are providing COVID-19 solutions | It's all hands on deck in Houston in the battle against coronavirus — and local biotech startups have risen to the occasion.
From mental health solutions and online portals to virtual medicine and new treatments, these Houston companies hav... |
| Feb 19, 2020 | Houston energy tech entrepreneur plans for growth following $15M series B raise | After years of having to educate potential customers about the game-changing technology that artificial intelligence can be, Alex Robart, CEO of Ambyint, says it's a different story nowadays.
"We're seeing our customers spend a little ... |
| Aug 13, 2019 | Houston cancer-fighting biotech company introduces its 4th ongoing clinical trial | A Houston-based biotech company has wrapped up enrollment for its most recent clinical trial of its cancer-fighting drug.
Moleculin Biotech Inc. (Nasdaq: MBRX) has launched its fourth ongoing trial — this time focusing on Cutaneous T-Cell L... |
| Apr 11, 2019 | 5 Houston biotech companies taking health care to new levels | Houston is the home of the largest medical center in the world, so it comes as no surprise that the Bayou City is also home to breakthrough technologies. Here are five Houston companies developing some of this biotech advancements.
Moleculi... |
| Feb 25, 2019 | 4 health-focused Houston innovators to know this week | This week's innovators to know are focused on health and wellness, from a Houston-based cryotherapy franchise to the person behind funding medical device and digital health startups. We couldn't narrow these folks down to the usual three, s... |
| Feb 15, 2019 | Houston biotech company aims to enhance oncology treatment of highly resistant cancers | Immunotherapy and personalized medicine get all the headlines lately, but in the fight against cancer, a natural compound created by bees could beat them in winning one battle.
In 2007, chairman and CEO Walter Klemp founded Moleculin Biotec... |
| Feb 5, 2019 | Amgen, Sanofi back a round for real-world evidence platform tech; Daiichi Sankyo's pexidartinib secures speedy FDA review | → Aetion has garnered $27 million from a new venture round that includes some of the biggest names in healthcare. The company plans to use the cash to build up its platform of real-world evidence data, a burgeoning field wher... |
| Jun 29, 2016 | The biotech IPO feast flags as investors lose their appetite for R&D risk | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. But from 2013 through 2015 generalist investors got over their fears and jumped into one of the hottest stock games on the planet. Fund... |
| Jun 3, 2016 | Moleculin Biotech Completes NASDAQ IPO Raising $9.24M | Moleculin Biotech, Inc., (NASDAQ: MBRX), a Houston, TX-based preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cance... |
| Nov 30, 2015 | Medical device startup, Soliton Inc., brings in $9M | Walter Klemp, Soliton’s CEO, has previously worked with M.D. Anderson spinoff companies. He was previously the CEO of Tyrell Inc., which created the acne treatment device Zeno, and according to his LinkedIn page is also the CEO of pharmaceu... |
| Medical device startup, Soliton Inc., brings in $9M | Soliton Inc., a Houston-based medical device startup has raised $9 million for further development of technology created at the University of Texas M.D. Anderson Cancer Center, according to an SEC filing.
Soliton’s technology is designed to... |
